1. Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455–7464
2. Ayala G, Li RL, Yang G, Wheeler T, Spitler J, Frolov A, Thompson T, Harper W (2003) High levels of P-Akt in prostate cancer and normal tissues are independent predictors of biochemical recurrence. J Urol 169: 601
3. Bubley GJ, Masiello D, McKnight N, Smith B, Mohi G, Neel B, Balk S (2003) The effect of combination growth factor receptor and mTOR inhibitors in androgen-independent prostate cancer cell lines. Clin Cancer Res 9: 6179S–6180S
4. Cancer Research UK (2004) Cancer Research UK web site. Cancer Stats. Mortality-UK.
http://www.Cancerresearchuk.Org
5. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV (2005) The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24: 7482–7492